Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intra-Cellular Therapies, Inc. announced positive topline results from Study 403 evaluating lumateperone 42mg as monotherapy in the treatment of major depressive episodes in patients with major... | March 29, 2023
Biomea Fusion, Inc. announced initial positive topline data for the first two cohorts of patients with type 2 diabetes mellitus enrolled in the Phase II portion of its ongoing Phase I/II clinical... | March 29, 2023
Topline Data Expected in 2Q 2023SEATTLE, Wash. and VANCOUVER, British Columbia, March 29, 2023 -- Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global... | March 29, 2023
Positive topline data from BDC-1001 dose-escalation clinical study validates the ability of the Boltbody™ ISAC platform to generate anti-tumor activity with acceptable safetyBDC-1001 advances... | March 29, 2023
Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with Fragile X syndrome; topline results expected first-half 2024 European Commission granted... | March 28, 2023